ZAS Corporation is proud to collaborate with the Rheumatology Department of BIRDEM General Hospital to introduce three world-class biosimilar therapies […]
ZAS Corporation Ltd. was honored to take part in the 33rd International Scientific Conference & 51st AGM of the Obstetrical
ZAS Corporation’s Dermatology Division recently organized a Continuing Medical Education (CME) program at BIDSA, focusing on “The Role of Adalimumab
ZAS Corporation recently organized a series of training sessions across multiple hospitals, engaging ICU nurses on the safe and effective
ZAS Onco, a division of ZAS Corporation Ltd., in collaboration with the Medical Oncology Society of Bangladesh (MOSB), recently organized
ZAS Ophthalmic, a concern of ZAS Group, proudly launched two innovative ophthalmic products — Timo-COMOD and Pollival — in the
Our Baby Care team recently hosted an engaging and insightful Round Table discussion with leading pediatricians, focusing on the prevention
ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland, for preventing recurrent urinary tract infections (UTIs).
In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology (NIKDU), ZAS Corporation Ltd. hosted
ZAS Corporation proudly participated in the prestigious MOSB Congress 2024, reaffirming its dedication to advancing oncology care in Bangladesh. The